| 33285 | The provider inserts a cardiac rhythm monitor with self–contained electrodes into a pocket in the tissues beneath the patient's skin and programs the device according to manufacturer’s directions. | 110 | $2,260 | $237.7K |
| 78492 | In this diagnostic procedure, the provider performs a myocardial perfusion PET imaging study which means it reveals the flow of oxygenated blood to the heart muscles. The service also includes… | 90 | $1,050 | $96.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,070 | $70 | $77K |
| 93306 | The provider uses transducers to obtain two–dimensional (2D) images of the heart structures through the chest wall. He evaluates the anatomy and function of all four heart chambers, valves, adjacent… | 1,010 | $70 | $74.9K |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 120 | $600 | $70.8K |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system,… | 2,070 | $20 | $49.7K |
| 78431 | The provider performs a PET myocardial imaging scan, a type of nuclear imaging test, with CT transmission scan that reveals blood flow to and from the heart (perfusion). Ejection fraction and… | 30 | $1,670 | $43.3K |
| 93298 | The provider, who is a physician or other qualified healthcare professional, evaluates the data from a previously implanted subcutaneous cardiac rhythm monitor system via telemetric communication for… | 2,080 | $20 | $37.4K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 240 | $120 | $27.9K |
| J2785 | Injection, regadenoson, 0.1 mg | 550 | $50 | $24.6K |